Loading interface...

Vagacyte 450 mg Tablet

Manufactured byPanacea Biotec Ltd.
Description

Vagacyte 450 mg Tablet belongs to the class of antiviral medicines. It is used for the prevention of Cytomegalovirus (CMV) infection which may occur after an organ transplantation. It is also used to treat CMV eye infection in patients with acquired immunodeficiency syndrome (AIDS). This medicine should not be taken if you are pregnant or are planning to get pregnant.

Substitutes

List of substitutes for Vagacyte 450 mg Tablet

VIROLFI 450 mg TABLET
Zydus Cadila

Side effects

Major & minor side effects for Vagacyte 450 mg Tablet

  • Chills
  • Headache
  • Shortness of breath
  • Diarrhea
  • Abdominal and stomach pain
  • Nausea and Vomiting
  • Back pain
  • Seizures
  • Swelling of legs
  • Itching
  • Decreased urine output

Uses of Vagacyte 450 mg Tablet

What is it prescribed for?

  • Cytomegalovirus Retinitis
  • Cytomegalovirus Prophylaxis
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its effect is not clinically established.
  • How long do the effects of this medicine last?
    The time until which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendency has been reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women except in life-threatening conditions. Discuss all the risks and benefits with your doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. Your doctor may advise you to discontinue the medicine or to discontinue breastfeeding based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to valganciclovir or ganciclovir or any other medicines of the same class.

Hemodialysis

This medicine is not recommended for use in patients with severe kidney disease and in patients who are undergoing hemodialysis.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women except in life-threatening conditions. Discuss all the risks and benefits with your doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. Your doctor may advise you to discontinue the medicine or to discontinue breastfeeding based on your clinical condition.
General warnings

Impairment of Fertility

This medicine should be used with caution due to the increased risk of impairment of fertility in both men and women. Replacement with a suitable alternative may be required based on the clinical condition of the patient. Do not stop the use of any medicine without consulting your doctor.

Missed Dose

If a dose of Vagacyte 450 mg Tablet is missed, take the dose as soon as you remember it. If it is almost the time for the next dose, skip the missed dose and take the next dose. Do not double the dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Infliximab

Trimethoprim

Zidovudine

Didanosine

Disease interactions

Hematologic Toxicities

This medicine should be used with caution in patients with a known history of blood disorders due to the increased risk of worsening of the condition. Close monitoring of blood cell counts is necessary while receiving treatment with this medicine. Replacement with a suitable alternative may be required based on the clinical condition of the patient.
Food interactions
Information not available.
Lab interactions
Information not available.
Take Vagacyte 450 mg Tablet exactly as instructed by the doctor. Do not take larger amounts than prescribed. Ensure that the course of treatment is completed. Report any adverse effects to the doctor on priority. Do not stop taking this medicine without consulting your doctor.
Miscelleneous

To be taken with food

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Vagacyte 450 mg Tablet works by blocking the growth and reproduction of Cytomegalovirus. This helps in preventing the spread of the disease.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Purine nucleosides, Antiviral agents

Schedule

N/A

[Internet]. 2017 [cited 28 July 2017]. Available from:

https://www.medicines.org.uk/emc/medicine/9315

DailyMed - VALGANCICLOVIR- valganciclovir hydrochloride tablet, film coated [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 28 July 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=37b7a5d8-9a2c-40b1-a414-71ecc47e567d

Valganciclovir: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 28 July 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a605021.html

Prescribing medicines in pregnancy database [Internet]. Therapeutic Goods Administration (TGA). 2017 [cited 28 July 2017]. Available from:

http://www.tga.gov.au/prescribing-medicines-pregnancy-database
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 4 Aug 2017

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.